During his morning conference, the Mexican president, Andrés Manuel López Obrador, confirmed that the government of Alberto Fernández in Argentina received the Undersecretary of Prevention and Health Promotion, in the Ministry of Health (SSa), Dr. Hugo López-Gatell, to talk about the agreement between these two countries to coordinate in the local production of the Oxford-AztraZeneca vaccine as well as to exchange information on the Russian vaccine, Sputnik V.
“To see the protocols, to see the technical and scientific elements, reactions in the application, everything that can be obtained from information to see if this vaccine can also be acquired”, were the words of the president with which he confirmed the fact.
López-Gatell’s visit to Argentina was announced by the Director General of American Regional Organizations and Mechanisms of the Ministry of Foreign Relations (SRE), Efraín Guadarrama, who accompanies the undersecretary of the SSa. According to a post on Twitter, both officials are in Argentina with “A work agenda focused on international cooperation in health matters and information exchanges on different vaccine initiatives”.
This was also mentioned a few minutes ago by Dr. Hugo López Gatell through his Twitter account: “We have the mandate of the president @lopezobrador_ [Andrés Manuel López Obrador] to meet with the president of Argentina, @alferdez [Alberto Fernández] and the Vice Minister of Health, @carlavizzotti [Carla Vizzotti], to exchange information on vaccines against # COVID19 “.
The agreement between the government of Mexico and Argentina was announced in August 2020. This is an effort by both countries to have a local production of the vaccine against the SARS-CoV-2 virus and avoid logistical problems related to its transport. With this objective, Argentina will be in charge of the preparation of the drug while Mexico will be responsible for its final packaging and distribution.
The agreement between Mexico and Argentina will also benefit the other Latin American countries. The vaccine produced in Argentina by the mAbxience laboratory, and shipped in Mexico with funding from Grupo Slim, in cooperation with the University of Oxford, which developed the drug, will offer the countries of the Latin American region a more accessible and economical option to immunize their populations against the pandemic virus.
Further, Dr. Hugo López-Gatell is in the South American country to exchange information about the effects and safety of the Russian vaccine, Sputnik V.
In Argentina, the vaccine promoted by the Vladimir Putin government has generated controversy due to the cases of adverse effects registered. Have even been created anti-drug groups claiming that the vaccine contains particles from aborted fetuses.
Faced with these rumors and conspiracy theories, in Argentina, various characters (ranging from journalists to celebrities) and organizations, among which are the Mothers of Plaza de Mayo Line Founder Tucumán, signed an open letter in which they exhort the media to make a professional treatment of the information regarding the Russian vaccine.
Between the groups designated to promote this campaign against vaccination is Let’s change, a right-wing political group in Argentina, also known for its position against legal abortion, which was approved by the seando of the South American country on December 30.
The government of Alberto Fernández will receive more than 300 thousand doses of the Russian vaccine, while he has already applied 39,599 doses of it to medical personnel in the country as part of its national vaccination campaign that began on December 29. To date, the Argentine Ministry of Health, together with the National Commission for Vaccine Safety, has reported 1,088 Events Supposedly Attributed to Vaccines and Immunizations (ESAVI).
The Integrated Health Information System of Argentina (SIISA) is in charge of receiving the reports from ESAVIs. According to this dependency, of the adverse effects caused by Sputnik V against the SARS-CoV-2 virus, 39.7% correspond to fever, headache and / or myalgia that started six and eight hours after vaccination. Furthermore, 99.3% of the reported events were mild and moderate.
The numbers reported by the SIISA put the Russian vaccine in a position comparable, in relation to the adverse effects of the drug, with the drug developed by the laboratories of Pfizer / BioNTech with which more than 40 thousand Mexican men and women have been protected against COVID-19.
In a document released from the purchase of the Pfizer vaccine by the Canadian government, the pharmaceutical company revealed the statistics regarding the adverse effects caused by its vaccine. Among them it stands out that 74.2% of people between 18 and 55 years of age who participated in Phase III clinical trials, had some reaction after the second dose of the vaccine. However, the vast majority of these effects were moderate to mild and disappeared within days of vaccination.
Among the adverse effects of the Pfizer / BioNTech vaccine applied in Mexico are injection site pain (84.1% of the time), fatigue (62.9%), headache (55.1%), muscle pain (38.3%), colds (31.9%), joint pain (23.6%), and fever (14.2%).
The Sputnik V vaccine applied by the Argentine government is currently in the process of being approved by the Federal Commission for Protection Against Sanitary Risks (COFEPRIS) of the Mexican government, as reported by the Secretary of Foreign Relations, Marcelo Ebrard. Sputnik V, which will be discussed by the delegates in Argentina of the Mexican government, is still waiting for its approval to start Phase III trials in Mexico.
Agreement to produce the Oxford and AstraZeneca vaccine against COVID-19
Mexico approved the emergency use of the AstraZeneca vaccine against COVID-19, announced Marcelo Ebrard
For commercial purposes, Mexican businessmen set their sights on Sputnik V, the Russian vaccine against COVID-19
“The relationship will grow”: Marcelo Ebrard met with the new Argentine ambassador and predicted a good future between both countries